论文部分内容阅读
目的:观察生脉注射液辅助治疗肝癌术后患者的临床疗效。方法:40例肝癌术后患者,随机分为对照组15例和治疗组25例。对照组予西医常规疗法,治疗组在对照组基础上加予生脉注射液。比较2组患者临床症状改善情况、引流管拔出时间、不良反应发生情况及住院时间。结果:治疗组术后疲乏、汗出、气短、腹胀改善时间均较对照组短,2组比较,差异均有统计学意义(P<0.05)。治疗组术后引流管拔出时间、住院时间与对照组比较,差异均有统计学意义(P<0.05)。结论:生脉注射液辅助治疗肝癌术后患者在改善其术后不良反应方面疗效显著,可减少住院时间,促进患者快速康复。
Objective: To observe the clinical effect of Shengmai injection in the treatment of postoperative liver cancer patients. Methods: Forty patients with postoperative liver cancer were randomly divided into control group (n = 15) and treatment group (n = 25). The control group was given conventional western medicine, and the treatment group was given Shengmai injection on the basis of the control group. The improvement of clinical symptoms, the drainage time of drainage tube, the incidence of adverse reactions and hospital stay were compared between the two groups. Results: After treatment, fatigue, sweating, shortness of breath and bloating time in the treatment group were shorter than those in the control group. There was significant difference between the two groups (P <0.05). The drainage time of drainage tube and length of stay in the treatment group were significantly different from those in the control group (P <0.05). Conclusion: Shengmai injection in the treatment of postoperative liver cancer patients with significant improvement in their adverse reactions after surgery, can reduce hospital stay and promote rapid recovery of patients.